Regeno Blend – BPC-157 / TB-500 / Cartalax (10MG/10MG/20MG)

Description The Regeno Blend is a specialized research reagent containing three distinct synthetic peptides, designed to facilitate advanced in vitro and ex vivo investigations into musculoskeletal, dermal, and articular repair mechanisms. BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide widely researched for its role in modulating vascular stabilization and nitric oxide (NO) signaling. TB-500 is a synthetic functional analogue of Thymosin β-4, an endogenous protein critical for actin polymerization and progenitor cell recruitment. Cartalax (Ala-Glu-Asp) is a highly membrane-permeable tripeptide bioregulator investigated for its capacity to interact directly with DNA and histone proteins to regulate gene expression related to cartilage and collagen synthesis. In experimental models, the concurrent administration of these three peptides allows researchers to observe multi-tiered healing responses. By merging the vascular-stabilizing properties of BPC-157 with the migratory support of TB-500 and the chondrogenic gene-modulating effects of Cartalax, this blend acts as a robust chemical probe for studying accelerated tissue scaffold integration and cellular hypertrophy under stress or mechanical overload. Biochemical Characteristics Sequence/Structure: A proprietary blend of three distinct peptide structures. BPC-157 (15 amino acids); TB-500 (synthetic Tβ4 sequence); Cartalax (tripeptide sequence: Ala-Glu-Asp). Receptor Affinity & Binding: Simultaneously targets VEGFR2 activation (BPC-157), G-actin monomer sequestration (TB-500), and intracellular epigenetic regulation markers linked to chondrocyte differentiation (Cartalax). Stability: Supplied as a co-lyophilized salt to prevent hydrolytic degradation and ensure the structural integrity of all three peptide chains during long-term storage. Specificity: Designed to competitively stimulate localized vascular, cytoskeletal, and structural repair mechanisms while minimizing off-target systemic inflammation in isolated cellular assays. Chemical Properties Property Specification Molecule Name Regeno Blend (BPC-157 / TB-500 / Cartalax) Synonyms Pentadecapeptide / Thymosin β-4 / AED Tripeptide Molecular Formula BPC-157: C62H98N16O22 TB-500: C212H350N56O78S Cartalax: C12H19N3O8 Molecular Weight BPC-157: 1419.5 g/mol TB-500: 4963.4 g/mol Cartalax: 333.3 g/mol Form Lyophilized Powder Purity ≥99% (Verified via HPLC for all components) Solubility Soluble in water and aqueous buffers (refer to SDS) Documentation COA and SDS available per lot